D-0436-2015 Class II Terminated

Recalled by Heritage Pharmaceuticals, Inc. — Eatontown, NJ

FDA drug recall D-0436-2015 was initiated by Heritage Pharmaceuticals, Inc. on Mar 25, 2015 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: Out of specification for unknown impurity. The recall status is terminated (terminated May 15, 2017). Affected quantity: 6,816 Bottles.

Recall details

Product Type
Drugs
Report Date
Apr 15, 2015
Initiation Date
Mar 25, 2015
Termination Date
May 15, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6,816 Bottles

Product description

GLIPIZIDE and METFORMIN HYDROCHLORIDE Tablets, USP, 2.5 mg/500 mg, 100 ct Bottles, Rx Only. Manufactured for: Heritage Pharmaceuticals Inc. Eatontown, NJ 07724, NDC: 23155-116-01.

Reason for recall

Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.

Distribution pattern

U.S. Nationwide including Puerto Rico.

Code information

Lot #:18020994, Expiry: October 2015; Lot #: 18021311, Expiry: November 2015.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0436-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0436-2015. Report a data issue: hello@regdatalab.com.